131 related articles for article (PubMed ID: 4142798)
1. Studies on lividomycin. I. In vitro antibacterial activities of LVDM against clinical isolates of Mycobacterium tuberculosis.
Shimizu T
Jpn J Antibiot; 1974 Dec; 27(6):766-74. PubMed ID: 4142798
[No Abstract] [Full Text] [Related]
2. Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis.
Tsukamura M; Mizuno S
J Gen Microbiol; 1975 Jun; 88(2):269-74. PubMed ID: 50402
[TBL] [Abstract][Full Text] [Related]
3. [Critical concentrations for resistances of tubercle bacilli to tuberactinomycin-N, viomycin, capreomycin, and lividomycin in patients treated with these agents (cross-resistance-relationships among resistances to aminoglucoside-antibiotics found during chemotherapy for tuberculosis) (author's transl)].
Tsukamura M; Mizuno S; Murata H; Oshima T
Kekkaku; 1975 May; 50(4-5):123-30. PubMed ID: 49449
[No Abstract] [Full Text] [Related]
4. [Susceptibility of drug-resistant tubercle bacilli isolated from pulmonary tuberculosis in patients to paromomycin (Aminosidine) (author's transl)].
Endo K
Jpn J Antibiot; 1974 Apr; 27(2):141-3. PubMed ID: 4136451
[No Abstract] [Full Text] [Related]
5. [Interactions of antitubercular drugs. II. Combined effects of rifampin, ethambutol, capreomycin, viomycin, ethionamide and cycloserine on mycobacterial growth in vitro].
Janowiec M; Zwolska-Kwiek Z
Pneumonol Pol; 1983 Dec; 51(12):607-12. PubMed ID: 6199778
[No Abstract] [Full Text] [Related]
6. [Cross-resistance of tubercle bacilli (a review) (III) (author's transl)].
Tsukamura M
Kekkaku; 1977 Apr; 52(4):171-5. PubMed ID: 69737
[No Abstract] [Full Text] [Related]
7. [Drug resistance of tubercle bacilli -- from the clinical point of view (author's transl)].
Fukuhara Y
Kekkaku; 1976 Dec; 51(12):477-87. PubMed ID: 65494
[No Abstract] [Full Text] [Related]
8. Resistance system of Mycobacterium bovis B.C.B. to aminoglycoside- and peptide-antibiotics. Comparison of resistant phenotypes between Mycobacterium tuberculosis and Mycobacterium bovis.
Tsukamura M
Microbiol Immunol; 1980; 24(1):11-9. PubMed ID: 6153747
[No Abstract] [Full Text] [Related]
9. [Studies on the effect of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). I. Studies in vitro].
Ota Y
Kekkaku; 1971 Aug; 46(8):295-301. PubMed ID: 4328204
[No Abstract] [Full Text] [Related]
10. [Activities of rifampicin, capreomycin, viomycin or kanamycin against Mycobacterium tuberculosis isolated from tuberculosis patients].
Endo K
Jpn J Antibiot; 1970 Aug; 23(4):387-9. PubMed ID: 4321638
[No Abstract] [Full Text] [Related]
11. Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin.
McClatchy JK; Kanes W; Davidson PT; Moulding TS
Tubercle; 1977 Mar; 58(1):29-34. PubMed ID: 68613
[TBL] [Abstract][Full Text] [Related]
12. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM and TUM. I. The sensitivity of human tubercle bacilli isolated from patients to the five antibiotics (author's transl)].
Saito T; Fukuhara Y
Kekkaku; 1974 Mar; 49(3):57-61. PubMed ID: 4136031
[No Abstract] [Full Text] [Related]
13. Investigation into the relationship of M ulcerans to M. buruli and other mycobacteria.
Schröder KH
Am Rev Respir Dis; 1975 Apr; 111(4):559-62. PubMed ID: 47730
[TBL] [Abstract][Full Text] [Related]
14. Study on tuberactinomycin-N. I. In vitro Antibacterial activity of TUM-N on Tubercle bacilli isolated from patients.
Shimizu T
Jpn J Antibiot; 1974 Aug; 27(4):463-70. PubMed ID: 4140247
[No Abstract] [Full Text] [Related]
15. [Evaluation of kanamycin, viomycin and capreomycin resistance of Mycobacterium tuberculosis].
Tomoda T; Minami Y; Maekawa Y; Oi Y
Rinsho Byori; 1971 Jun; 19(6):423-6. PubMed ID: 4111341
[No Abstract] [Full Text] [Related]
16. Mode of action of antituberculous drugs and mechanisms of drug resistance in Mycobacterium tuberculosis.
Rastogi N; David HL
Res Microbiol; 1993 Feb; 144(2):133-43. PubMed ID: 8337471
[No Abstract] [Full Text] [Related]
17. [In vitro antituberculous activity of lividomycin].
Kobayashi F; Nagoya T; Eda J; Yoshimura Y
Jpn J Antibiot; 1972 Dec; 25(6):360-6. PubMed ID: 4125073
[No Abstract] [Full Text] [Related]
18. [Development of resistance of Mycobacterium tuberculosis to cycloserine, ethionamide, kanamycin, florimycin in experiments in vitro].
Mkrtchian SV
Antibiotiki; 1968 Oct; 13(10):907-10. PubMed ID: 4303355
[No Abstract] [Full Text] [Related]
19. [The degree of cross-resistance to kanamycin (KM) of tubercle bacilli resistant to capreomycin (CPM), and the degree of cross-resistance to KM and CPM of tubercle bacilli resistant to viomycin (VM) (author's transl)].
Inagake H; Yamadori H; Inoue N; Mabuchi H; Ikeda N; Maekawa N
Kekkaku; 1980 Jul; 55(7):323-30. PubMed ID: 6162994
[No Abstract] [Full Text] [Related]
20. Drug-resistant Mycobacterium tuberculosis in Korean isolates.
Carpenter JL; Covelli HD; Avant ME; McAllister CK; Higbee JW; Ognibene AJ
Am Rev Respir Dis; 1982 Dec; 126(6):1092-5. PubMed ID: 6185025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]